Hims & Hers Q3 2026: Gross Margin Collapse Turns Growth Into a Loss
Hims & Hers reported Q3 2026 revenue of $890.4M, up 49% YoY but below estimates. GAAP loss of $0.14 per share missed expectations. Gross margin fell to 57% from 74% YoY. International revenue surged 321% while domestic grew 21%. Full-year EBITDA guidance was reduced. Free cash flow dropped 72% YoY to $26M.
How this was made
The 30-second read
Why it matters
The earnings miss and guidance cut suggest near‑term earnings volatility, but growth metrics remain robust.
Market read
The earnings release provides fresh data that could move HIMS stock and influence sentiment in the broader digital health sector.
What to watch
Strong subscriber growth and 30% increase in revenue per subscriber may offset short‑term margin pain.
Background
Hims & Hers is a telehealth company that has been expanding internationally and investing in AI‑driven care experiences.
Ticker impact
Q3 2026 earnings show revenue up 49% but gross margin fell to 57% and guidance lowered, indicating profit pressure.
downward pressure as investors price in weaker margins and lower guidance
The company missed profit expectations, cut full-year EBITDA guidance, and reported a sharp margin decline, all of which typically trigger sell‑offs.
Market effects
Telehealth and digital health stocks may face scrutiny over margin sustainability.
U.S. market, particularly consumer health and tech‑enabled services.
Limited to investors with exposure to Hims & Hers and similar growth‑stage health platforms.
Counterpoint
Margin compression could be temporary as AI‑native care and international expansion drive longer‑term profitability.
Key entities
- personAndrew Dudum
CEO of Hims & Hers, provided commentary on the quarter.
